Allara, a virtual women’s health provider, has raised $30 million.
The round, the series of which was not disclosed, brings the company’s total to $75 million. It was led by Index Ventures and GV (Google Ventures), alongside new investors Camino Partners, Foreground and Family Fund. The new funding will accelerate enterprise partnerships, expand Allara’s clinical infrastructure and support more AI features.
Allara, founded in 2020, has expanded to serve a broader continuum of women’s health. The company aims to fill gaps in care for women often navigating an array of specialists. Each Allara patient is paired with a multidisciplinary team, including OB-GYNs, endocrinologists, registered dietitians and patient success leads.
Since its expansion nationwide last year, Allara has added urgent care visits for things like UTIs, bacterial vaginosis (BV) and STDs, and brought on more internal medicine providers to its interdisciplinary care team. It has also launched more supplements and medication delivery services.
“The whole thesis of why we started Allara is that the traditional healthcare system did not have the time or capacity to treat the complex care needs that our patients have,” Allara founder and CEO Rachel Blank told Fierce Healthcare.
Allara manages everything from PMOS to hyperthyroidism to weight management to hormonal dysregulation to pre-conception. Many Allara patients come to the company without a diagnosis. Some come with chronic conditions. A third have anxiety or depression, a common comorbidity for hormonal conditions.
“The patients that we tend to see tend to have a pretty complex set of problems,” Blank said. For instance, say a woman in midlife comes in because of irregular periods. Allara’s assessment uncovers she has metabolic health issues, such as high cholesterol. “I think that’s a really unique part of what we’re able to do because we’re taking this whole health look for our patients,” Blank noted.
Allara has partnerships with providers for when a patient needs to be referred to in-person care. It also integrates with LabCorp and Quest Diagnostics to make it easier for patients to book labs. “The idea is we know our patients have a lot of care needs, so we try to make it as easy and convenient for them to really guide them through the healthcare system,” Blank said.
To help optimize their health before they get pregnant, Allara helps patients regulate their cycles or get metabolic health support. Even when a patient then goes to see an OB in-person, they return to Allara, per Blank, because there is a huge drop-off in regular visits after birth. Allara can also treat PMDD in-house (though depression and anxiety are handled externally through referrals).
"Helping patients in this pre-fertility moment … has been really instrumental in improving pregnancy outcomes for our patients,” Blank said.
Over the past year, Allara has invested more heavily in AI tooling for its providers, though Blank believes AI can never truly replace physicians. Instead, the goal is to support admin tasks to maximize how much time clinicians can spend with patients. Allara most often hears in positive feedback that patients feel heard and validated. “Speaking to a human doctor is incredibly important especially as they are dealing with these much more complex and chronic care needs,” Blank noted. Today, Allara providers use AI scribes and an AI copilot during visits for clinical decision support.
When it comes to patient-facing AI, Allara plans to soon launch a new app with a conversational interface to help patients more easily navigate Allara. They don’t need to know their diagnosis or what specific type of visit they need; they can talk to the chatbot for personalized recommendations. “You really could come in for almost anything when it comes to your healthcare,” Blank said.
Allara works with major commercial payers and is starting to increase awareness of Allara as a benefit among employers that already have it as part of their insurance contracts. It has seen 120,000 women to date.